期刊文献+

巨噬细胞及其表达和分泌产物在类风湿性关节炎发病中的作用 被引量:9

Role of Macrophages and Their Products in the Pathogenesis of Rheumatoid Arthritis
下载PDF
导出
摘要 巨噬细胞分化自外周血单核细胞,二者在类风湿性关节炎(rheumatoid arthritis,RA)的发病过程中起着关键性的作用。这些细胞参与了炎症的启动和维持、白细胞的黏附和迁移、基质的降解和血管新生。巨噬细胞表达黏附分子、趋化因子受体(chemokine receptor,CR)和其他表面抗原;它们还分泌趋化因子、细胞因子、生长因子、蛋白酶和其他介质。这些炎症介质是关节炎中炎症和血管新生发生的重要病理机制。近年来,巨噬细胞移动抑制因子(macro-phage migrationinhibitory factor,MIF)受到研究者们的广泛关注,这种细胞因子可由包括巨噬细胞在内的多种细胞产生,它反过来可以促进巨噬细胞的活化和细胞因子的产生;同时,它可以调节机体对糖皮质激素的敏感性;并且将类风湿性关节炎与动脉粥样硬化等炎症疾病联系在一起。在类风湿性关节炎发病过程中,巨噬细胞还可以产生多种蛋白酶(如组织蛋白酶G,cathepsin G),这些蛋白酶促进了炎症和血管新生的发生。鉴于巨噬细胞及其表达和分泌产物在类风湿关节炎致病机理中具有关键性作用,它们已成为治疗类风湿性关节炎的一个理想靶点。 Macrophages differentiate from peripheral-blood monocytes.Both monocytes and synovial macrophages are key players in rheumatoid arthritis.These cells are involved in the initiation and perpetuation of inflammation,leukocyte adhesion and migration,matrix degradation and angiogenesis.Macrophages express adhesion molecules,chemokine receptors and other surface antigens.They also secrete a number of chemokines,cytokines,growth factors,proteases and other mediators.These inflammatory mediators are the pathological mechanisms of inflammation and angiogenesis in arthritis.In recent years,macrophage migration-inhibitory factor has drawn great attention.This cytokine is involved in macrophage activation and cytokine production.Meanwile,migration-inhibitory factor also regulates glucocorticoid sensitivity and may be a pathogenic link between rheumatoid arthritis and atherosclerosis.In rheumatoid arthritis,several proteinases including cathepsin G are produced by macrophages,and they are associated with inflammatory and angiogenic events.As macrophages and their products are key players in the pathogenesis of rheumatoid arthritis,they may become good therapeutic targets for treating arthritis.
出处 《自然杂志》 北大核心 2009年第5期262-267,共6页 Chinese Journal of Nature
关键词 巨噬细胞 趋化因子 趋化因子受体 血管新生 类风湿性关节炎 macrophage chemokine chemokine receptor angiogenesis rheumatoid arthritis
  • 相关文献

参考文献28

  • 1IMHOF B A, AURRAND-LIONS M. Adhesion mechanisms regulating the migration of monocytes[J]. Nat Rev Immunol, 2004, 4 (6):432-444. 被引量:1
  • 2GEISSMANN F, JUNG S, LITTMAN D R. Blood monocytes consist of two principal subsets with distinct migratory properties[J]. Immunity, 2003, 19 (1):71-82. 被引量:1
  • 3LIU H, HUANG Q, SHI B, et al. Regulation of Mcl-1 expression in rheumatoid arthritis synovial macrophages[J]. Arthritis Rheum, 2006, 54 (10) :3174-3181. 被引量:1
  • 4KOMANO Y, NANKI T, HAYASHIDA K, et al. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts[J]. Arthritis Res Ther, 2006,8 (5) : R152-R158. 被引量:1
  • 5奚正德,张冬青.关节炎性骨侵蚀和骨保护蛋白的作用[J].自然杂志,2004,26(6):324-327. 被引量:9
  • 6奚正德,张冬青.骨保护蛋白对类风湿疾病相关骨吸收的作用[J].国外医学(免疫学分册),2005,28(6):338-341. 被引量:7
  • 7KATSCHKE K J jr, ROTTMAN J B, RUTH J H, et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid and synovial tissue monocytes/macrophages in rheumatoid arthritis[J]. Arthritis Rheum, 2001, 44 (5) : 1022-1032. 被引量:1
  • 8SUNAHORI K, YAMAMURA M, YAMANA J, et al. Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis[J]. Arthritis Rheum, 2006,54 (1) :97-104. 被引量:1
  • 9SHAHRARA S, PROUDFOOT A E, PARK C C, et al. Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis [J]. J Immunol, 2008, 180 (5) : 3447-3456. 被引量:1
  • 10ANTONIV T T, IVASHKIV L B. Dysregulation of interleukin-10 dependent gene expression in rheumatoid arthritis synovial macrophages[J]. Arthritis Rheum, 2006,54 (9) : 2711- 2721. 被引量:1

二级参考文献77

  • 1奚正德,马宝骊.类风湿性关节炎的骨髓源学说[J].自然杂志,1998,20(6):318-322. 被引量:7
  • 2奚正德,李宁丽,张雁云,张冬青,臧敬五.滑膜成纤维细胞在关节炎发病中的作用[J].自然杂志,2004,26(4):205-209. 被引量:15
  • 3奚正德,张冬青.关节炎性骨侵蚀和骨保护蛋白的作用[J].自然杂志,2004,26(6):324-327. 被引量:9
  • 4[25]Fleischmann RM,Schechtman J,Bennett R,et al.Anakinra,a recombinant human interleukin-1 receptor antagonist (rmetHuIL-1ra),in patients with rheumatoid arthritis:A large,international,multicenter,placebo-controlled trial.Arthritis Rheum,2003,48 (4):927-934 被引量:1
  • 5[2]Xi Z,Zhang J,Shen B,et al.Type Ⅱ collagen-specific T cells mediate the onset of arthritis.US.Chin J Lymphology Oncol,2004,3 (4):198-202 被引量:1
  • 6[6]Felson DT,Anderson JJ,Boers M,et al.American College of Rheumatology.Preliminary definition of improvement in rheumatoid arthritis.Arthritis Rheum,1995,38 (6):727-735 被引量:1
  • 7[7]Smolen JS,Kalden JR,Scott DL,et al.Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis:a double-blind,randomised,multicentre trial.European Leflunomide Study Group.Lancet,1999,353(9149):259-266 被引量:1
  • 8[8]Strand V,Cohen S,Schiff M,et al.Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate.Leflunomide Rheumatoid Arthritis Investigators Group.Arch Intern Med,1999,159 (21):2542-2550 被引量:1
  • 9[9]Cohen S,Cannon GW,Schiff M,et al.Two-year,blinded,randomized,controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate.Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.Arthritis Rheum,2001,44 (9):1984-1992 被引量:1
  • 10[10]Lee H,Kimko HC,Rogge M.Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis.Clin Pharmacol Ther,2003,73 (4):348-365 被引量:1

共引文献19

同被引文献149

引证文献9

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部